• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾酮与男性避孕。

Testosterone and male contraception.

机构信息

University of Washington, Division of Metabolism, Endocrinology and Nutrition, Seattle, Washington, USA.

出版信息

Curr Opin Endocrinol Diabetes Obes. 2024 Dec 1;31(6):236-242. doi: 10.1097/MED.0000000000000880. Epub 2024 Aug 19.

DOI:10.1097/MED.0000000000000880
PMID:39155802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11556877/
Abstract

PURPOSE OF REVIEW

Rates of unintended pregnancy have remained relatively stagnant for many years, despite a broad array of female contraceptive options. Recent restrictions on access to abortion in some countries have increased the urgency for expanding contraceptive options. Increasing data suggest men are keen to utilize novel reversible male contraceptives.

RECENT FINDINGS

Despite decades of clinical research in male contraception, no reversible hormonal product currently exists. Nestorone/testosterone, among other novel androgens, shows promise to finally move to pivotal Phase 3 studies and introduction to the marketplace.

SUMMARY

Hormonal male contraception utilizes androgens or androgen-progestin combinations to exploit negative feedback that regulates the hypothalamic-pituitary-testicular axis. By suppressing release of gonadotropins, these agents markedly decrease endogenous testosterone production, lower intratesticular testosterone and suppress spermatogenesis. The addition of a progestin enhances the degree and speed of sperm suppression. The androgen component preserves a state of symptomatic eugonadism in the male. There is growing demand and acceptance of male contraceptive options in various forms. As these formulations progress through stages of drug development, regulatory oversight and communication with developers around safety and efficacy standards and garnering industry support for advancing the production of male contraceptives will be imperative.

摘要

目的综述

尽管有多种女性避孕选择,但多年来,意外怀孕的发生率仍相对停滞不前。最近一些国家对堕胎的限制增加了扩大避孕选择的紧迫性。越来越多的数据表明,男性热衷于使用新型可逆男性避孕药。

最近的发现

尽管男性避孕药已有数十年的临床研究,但目前尚无可逆的激素类产品。去氧孕烯/睾酮等新型雄激素类药物有望最终进入关键的 3 期研究并推向市场。

总结

激素男性避孕药利用雄激素或雄激素-孕激素组合来利用调节下丘脑-垂体-睾丸轴的负反馈。这些药物通过抑制促性腺激素的释放,显著降低内源性睾酮的产生,降低睾丸内睾酮水平并抑制精子发生。孕激素的添加增强了精子抑制的程度和速度。雄激素成分使男性保持有症状的正常性腺状态。各种形式的男性避孕药的需求和接受度都在不断增加。随着这些制剂在药物开发的各个阶段取得进展,监管机构必须对安全性和有效性标准进行监督和与开发者进行沟通,并争取行业支持以推进男性避孕药的生产。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/11556877/3d2145e2bc27/coedo-31-236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/11556877/0c017bf05cda/coedo-31-236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/11556877/3d2145e2bc27/coedo-31-236-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/11556877/0c017bf05cda/coedo-31-236-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/11556877/3d2145e2bc27/coedo-31-236-g002.jpg

相似文献

1
Testosterone and male contraception.睾酮与男性避孕。
Curr Opin Endocrinol Diabetes Obes. 2024 Dec 1;31(6):236-242. doi: 10.1097/MED.0000000000000880. Epub 2024 Aug 19.
2
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
3
Synthetic androgens for male contraception.用于男性避孕的合成雄激素。
Contraception. 2025 May;145:110735. doi: 10.1016/j.contraception.2024.110735. Epub 2024 Nov 6.
4
WITHDRAWN: Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia.撤回:雄激素对比安慰剂或不治疗特发性少弱精子症。
Cochrane Database Syst Rev. 2007 Jul 18(4):CD000150. doi: 10.1002/14651858.CD000150.
5
Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia.雄激素与安慰剂或不治疗对特发性少弱精子症的疗效比较
Cochrane Database Syst Rev. 2000;1996(2):CD000150. doi: 10.1002/14651858.CD000150.
6
Steroid hormones for contraception in men.男性避孕用甾体激素。
Cochrane Database Syst Rev. 2004(3):CD004316. doi: 10.1002/14651858.CD004316.pub2.
7
Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.即刻与产后延迟放置避孕埋植剂和宫内节育器避孕效果比较。
Cochrane Database Syst Rev. 2022 Oct 27;10(10):CD011913. doi: 10.1002/14651858.CD011913.pub3.
8
Steroid hormones for contraception in men.男性避孕用甾体激素。
Cochrane Database Syst Rev. 2007 Apr 18(2):CD004316. doi: 10.1002/14651858.CD004316.pub3.
9
Inequality in modern contraceptive use and unmet need for contraception among women of reproductive age in Zambia. A trend and decomposition analysis 2007-2018.赞比亚育龄妇女现代避孕方法使用情况及未满足的避孕需求的不平等。2007 - 2018年趋势与分解分析
Reprod Health. 2024 Dec 9;21(1):181. doi: 10.1186/s12978-024-01909-8.
10
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.

引用本文的文献

1
Testosterone replacement therapy and spermatogenesis in reproductive age men.生殖年龄男性的睾酮替代疗法与精子发生
Nat Rev Urol. 2025 May 9. doi: 10.1038/s41585-025-01032-8.
2
Male Hormonal Contraception-Current Stage of Knowledge.男性激素避孕——当前的知识阶段
J Clin Med. 2025 Mar 23;14(7):2188. doi: 10.3390/jcm14072188.

本文引用的文献

1
Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy.TRAVERSE 试验中患有性腺功能减退症男性的抑郁综合征:对睾酮替代疗法的反应。
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1814-1826. doi: 10.1210/clinem/dgae026.
2
Cardiovascular Safety of Testosterone-Replacement Therapy.睾酮替代疗法的心血管安全性。
N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16.
3
Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone).
使用含睾酮和醋酸炔诺酮(内斯托酮)的每日自给药透皮凝胶进行国际男性避孕效果试验的设计
Contraception. 2023 Aug;124:110064. doi: 10.1016/j.contraception.2023.110064. Epub 2023 May 18.
4
Associations of Unintended Pregnancy With Maternal and Infant Health Outcomes: A Systematic Review and Meta-analysis.意外妊娠与母婴健康结局的关联:系统评价和荟萃分析。
JAMA. 2022 Nov 1;328(17):1714-1729. doi: 10.1001/jama.2022.19097.
5
Androgens in male contraception.雄激素在男性避孕中的应用。
Best Pract Res Clin Endocrinol Metab. 2022 Sep;36(5):101627. doi: 10.1016/j.beem.2022.101627. Epub 2022 Feb 23.
6
Male contraception: What do women think?男性避孕:女性怎么看?
Prog Urol. 2022 Mar;32(4):276-283. doi: 10.1016/j.purol.2021.11.003. Epub 2021 Dec 16.
7
Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β-MNTDC in healthy men.比较健康男性中孕激素雄激素二甲双胍十一酸酯和 11β-MNTDC 的代谢作用。
Andrology. 2021 Sep;9(5):1526-1539. doi: 10.1111/andr.13025. Epub 2021 May 22.
8
Will Men Use Novel Male Contraceptive Methods and Will Women Trust Them? A Systematic Review.男性会使用新型男性避孕药具吗?女性会信任它们吗?系统综述。
J Sex Res. 2021 Sep;58(7):838-849. doi: 10.1080/00224499.2021.1905764. Epub 2021 Apr 26.
9
Dimethandrolone Undecanoate, a Novel, Nonaromatizable Androgen, Increases P1NP in Healthy Men Over 28 Days.十一酸双氢睾酮,一种新型非芳香化雄激素,可在 28 天内增加健康男性的 PINP。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e171-e181. doi: 10.1210/clinem/dgaa761.
10
Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019.按收入、地区和堕胎合法状况划分的意外妊娠和堕胎:1990-2019 年综合模型估计。
Lancet Glob Health. 2020 Sep;8(9):e1152-e1161. doi: 10.1016/S2214-109X(20)30315-6. Epub 2020 Jul 22.